Skip to main content

News

head uk2

News

HMC-0309-041Get more information about:

  • Chitin and chitosan on the world wide web
  • Company news
  • Events
  • Publications and releases
  • Tips and tricks

Enjoy reading!

Press release mRNA active ingredients: Protected for an optimized effect

Berlin, Halle, 16.03.2023: Since January of this year, the project "Zielwirk" is developing a new chitosan technology for the efficient release of mRNA active ingredients. The technology aims to ensure that drugs for the treatment of serious diseases can be better absorbed as well as processed by the body. The participating project partners Heppe Medical Chitosan GmbH, FDX Fluid Dynamix GmbH, Martin Luther University Halle-Wittenberg and the Fraunhofer Institute for Production Systems and Design Technology (IPK) are funded by the German Federal Ministry of Economics and Climate Protection (BMWK) with six million euros over three years.

drug delivery, chitosan, nanoparticles

Katja Richter in the scientific committee of the EUCHIS conference 2023

We are very pleased to announce that Katja Richter, CEO of Heppe Medical Chitosan GmbH, has been appointed to the scientific committee of EUCHIS 2023. EUCHIS 2023, the International Conference of the European Chitin Society (EUCHIS 2023) and the 15th International Conference on Chitin and Chitosan (15th ICCC) will be held in Siglufjörður, Iceland, from September 11-14, 2023.

conference, EUCHIS

HMC at the ESAO Winterschool 2023 in Lutherstadt Wittenberg

From 15.02. to 18.02.2023 the ESAO Winterschool 2023 will take place in Lutherstadt Wittenberg. The Winterschool is organized by the Fraunhofer Institute for Microstructure of Materials and Systems (IMWS) and the Martin Luther University Halle-Wittenberg. Next to experts from the academic world, we, Heppe Medical Chitosan GmbH, will also be represented.

ESAO Winterschool

Arginine-chitosan nanoparticles for siRNA transport

Small interfering RNAs (siRNAs) can be used as in gene therapies for e.g. cancers such as leukemia. However, the application of these is limited by a lack of efficient drug delivery. Therefore, in the presented study, chitosan was functionalized with arginine to form nanoparticles, loaded with siRNA, and their properties as siRNA vectors were investigated.

drug delivery, nanoparticles, arginin chitosan

Publications and reviews with chitosan in 2022

According to HMC research (PubMed, Jan. 20, 2023), a total of 3097 publications with chitosan in the title were published in 2022. Of these, 151 were reviews with a wide variety of applications of chitosan. In this article, we would like to give you an overview of the publications and briefly introduce five of the reviews. Enjoy reading!

Publications

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.